Stock Analysis
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis
Adaptive Biotechnologies Corporation (ADPT) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Adaptive Biotechnologies Corporation (ADPT) currently has an AIQ Score of 39/100, indicating a bearish setup. Sentiment is the strongest factor at 73/100. Quality is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ADPT at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $24.28 |
| AIQ Score | 39/100 |
| Overall View | Bearish |
| Technical Analysis Consensus | Neutral |
| Market Cap | $3.9B |
| P/E Ratio | -59.37 |
| Forward P/E | — |
| EPS | -$0.25 |
| Revenue TTM | $71.55M |
| Dividend Yield | 0.00% |
| Beta | 2.09 |
| Volume | 1.4M |
| 52-week range | $12.00-$26.87 |
| RSI 14 | 45.95 |
| 50-Day SMA | $23.46 |
| 200-Day SMA | $17.68 |
| Analyst Price Target | $23.90 |
| Next Earnings | Nov 4, 2026 |
Create a free account to keep researching stocks
You have viewed 2 stock pages in the last 24 hours. Create a free account to keep researching current evidence.
ADPT
OverviewADPT Stock Analysis Summary
Adaptive Biotechnologies Corporation (ADPT) currently has an AIQ Score of 39/100, indicating a bearish setup. Sentiment is the strongest factor at 73/100. Quality is the weakest current factor at 30/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bearish regime, ADPT has AIQ Score of 39/100 with Sentiment base of 73/100 and fading Quality at 30/100. Wait for component alignment before adding exposure.
Sentiment (73/100) leads while Quality (30/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -1.18% stock move · ADPT classified in Biotechnology.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ADPT Bullish or Bearish Right Now?
ADPT currently has a bearish overall setup. Sentiment is the strongest factor at 73/100, while Quality is weakest at 30/100. The current evidence suggests a defensive setup.
- - Price is +3.49% above its 50-day SMA.
- - Value is the current constraint at 34/100.
- - Risk Resilience is weak at 35/100.
- - Analyst target implies -1.57% downside from the latest quote.
- - Technical consensus has more sell votes than buy votes (23 vs 18).
Current Consensus
ADPT's Technical Analysis Consensus is currently Neutral, with 18 buy, 4 neutral, and 23 sell votes. ADPT's 14-day RSI is 45.95, which places the stock in a neutral momentum range. ADPT's beta is 2.09, indicating greater market sensitivity than the broad market.
What Changed in ADPT?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the ADPT Outlook?
The current bearish outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ADPT Decision Framework
Public evidence layers, setup checks, and risk context for Adaptive Biotechnologies Corporation.
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis
Adaptive Biotechnologies Corporation has an AIQ Score of 39/100 in a Defensive regime. Sentiment is strongest at 73/100. Beta is 2.09, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ADPT is in a Defensive AIQ regime with score 39/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 73/100 while quality lags at 30/100. |
| Factor Evidence | Momentum 57/100 · Value 34/100 · Quality 30/100 · Risk 35/100 · Sentiment 73/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 73/100.
Momentum is 57/100 and RSI (14) is 46.0.
ADPT is in a Defensive regime at 39/100.
Risk factor is 35/100 with beta 2.09 and annual volatility 69.27%.
Current conflict: sentiment leads at 73/100 while quality lags at 30/100.
ADPT Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ADPT Fundamentals
ADPT valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ADPT Technical Analysis
ADPT technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ADPT Stock Catalysts
Track ADPT earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ADPT Dividend Analysis
ADPT dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ADPT Financial Data
ADPT revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ADPT Risk Analysis
ADPT volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ADPT Stock News
ADPT stock news, market tone, recent headlines, and catalyst context.
ADPT vs Internet / Consumer Tech Peers
Current peer cohort: ADPT · ALRM · API · CHGG · COMP. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ADPT Current stock | 39/100 | 34/100 | 57/100 | 35/100 | 1.19 | 69.27% | Current |
| ALRM Alarm.com | 66/100 | 67/100 | 68/100 | 69/100 | -0.01 | 30.99% | ADPT vs ALRM |
| API Agora | 56/100 | 53/100 | 55/100 | 58/100 | 0.67 | 51.51% | ADPT vs API |
| CHGG Chegg | 50/100 | 65/100 | 49/100 | 25/100 | -0.12 | 109.97% | ADPT vs CHGG |
| COMP Compass | 30/100 | 42/100 | 36/100 | 19/100 | 0.53 | 66.38% | ADPT vs COMP |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 5, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 6, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ADPT
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ADPT
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ADPT Stock FAQ
What is ADPT stock price today?
Adaptive Biotechnologies Corporation's current stock price is $24.28. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ADPT bullish or bearish right now?
ADPT's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ADPT's market cap?
ADPT's market cap is $3.9B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ADPT's current P/E ratio?
ADPT's current P/E ratio is -59.37 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ADPT's RSI?
ADPT's 14-day RSI is 45.95 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ADPT above its 50-day and 200-day moving averages?
ADPT is 3.49% from its 50-day SMA and 37.31% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ADPT's next earnings date?
ADPT's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ADPT pay a dividend?
ADPT's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.